These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 699981)

  • 1. Differences in the dopaminergic effects of the ergot derivatives bromocriptine, lisuride and d-LSD as compared with apomorphine.
    Horowski R
    Eur J Pharmacol; 1978 Sep; 51(2):157-66. PubMed ID: 699981
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopaminergic and serotonergic mediation of the discriminable effects of ergot alkaloids.
    Holohean AM; White FJ; Appel JB
    Eur J Pharmacol; 1982 Jul; 81(4):595-602. PubMed ID: 7117388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine effects of neuropsychotropic drugs and their possible influence on toxic reactions in animals and man -- the role of the dopamine-prolactin system.
    Horowski R; Gräf KJ
    Arch Toxicol Suppl; 1979; (2):93-104. PubMed ID: 288372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions.
    White FJ; Appel JB
    Science; 1982 Apr; 216(4545):535-7. PubMed ID: 7071600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locomotor effects of lisuride: a consequence of dopaminergic and serotonergic actions.
    Fink H; Morgenstern R
    Psychopharmacology (Berl); 1985; 85(4):464-8. PubMed ID: 2991961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoaminergic involvement in the behavioral effects of ergot derivatives.
    Appel JB; Cunningham KA; West KB
    Prog Clin Biol Res; 1985; 192():51-62. PubMed ID: 2867556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothermic action of lisuride in rats and differences to bromocriptine in the antagonistic effect of neuroleptics.
    Horowski R
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar; 306(2):147-51. PubMed ID: 36572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice.
    Horowski R; Wachtel H
    Eur J Pharmacol; 1976 Apr; 36(2):373-83. PubMed ID: 945166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of LSD and lisuride on A10 dopamine neurons in the rat.
    White FJ; Wang RY
    Neuropharmacology; 1983 Jun; 22(6):669-76. PubMed ID: 6888664
    [No Abstract]   [Full Text] [Related]  

  • 10. Anorectic effect of lisuride and other ergot derivatives in the rat.
    Carruba MO; Ricciardi S; Müller EE; Mantegazza P
    Eur J Pharmacol; 1980 Jun; 64(2-3):133-41. PubMed ID: 6105081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic and dopaminergic effects of yawning in the cat.
    Marini JL
    Pharmacol Biochem Behav; 1981 Nov; 15(5):711-5. PubMed ID: 7312907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation between the stimulus effects of (+)-lysergic acid diethylamide and lisuride using a three-choice, drug discrimination procedure.
    Callahan PM; Appel JB
    Psychopharmacology (Berl); 1990; 100(1):13-8. PubMed ID: 2296621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus properties of clonidine: substitution by ergot derivatives.
    Cunningham KA; Callahan PM; Craigmyle NA; Appel JB
    Eur J Pharmacol; 1985 Dec; 119(3):225-9. PubMed ID: 2868902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of neurotransmitter receptor binding by ergot derivatives.
    Hruska RE; Silbergeld EK
    J Neurosci Res; 1981; 6(1):1-11. PubMed ID: 6111611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine agonists increase pallidal unit activity: attenuation by agonist pretreatment and anesthesia.
    Bergstrom DA; Bromley SD; Walters JR
    Eur J Pharmacol; 1984 Apr; 100(1):3-12. PubMed ID: 6723776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of dopaminergic ergot derivatives with cyclic nucleotide system.
    Spano PF; Saiani L; Memo M; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 23():95-102. PubMed ID: 6249093
    [No Abstract]   [Full Text] [Related]  

  • 17. Blockade of photically induced epilepsy by 'dopamine agonist' ergot alkaloids.
    Anlezark G; Meldrum B
    Psychopharmacology (Berl); 1978 Apr; 57(1):57-62. PubMed ID: 96470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lisuride and transdihydrolisuride: differences in action on central dopaminergic functions in dependence on the location and the state of receptors.
    Krejci I; Schuh J; Prágerová H; Dlabac A
    Pol J Pharmacol Pharm; 1985; 37(3):263-71. PubMed ID: 4070078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of exploration in rats distinguish lisuride from lysergic acid diethylamide.
    Adams LM; Geyer MA
    Pharmacol Biochem Behav; 1985 Sep; 23(3):461-8. PubMed ID: 4048241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of the central dopaminergic system in the antireserpine effect of LSD.
    Menon MK; Clark WG; Masuoka DT
    Psychopharmacology (Berl); 1977 May; 52(3):291-7. PubMed ID: 406633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.